Assessment of neuron-specific enolase, S100B and malondialdehyde levels in serum and vitreous of patients with proliferative diabetic retinopathy

[11] Aubert RE(2015)The role of oxidative stress in neurodegenerative diseases Exp Neurobiol. 27 523.e11-523.e19

[12] Herman WH(2012)Plasma levels of oxidative stress biomarkers and hospital mortality in severe head injury: a multivariate analysis J Crit Care 17 1298-1304

[13] Joussen AM(2011)Lipid peroxidation and total antioxidant capacity in vitreous, aqueous humor, and blood samples from patients with diabetic retinopathy Mol Vis 92 548-551

[14] Poulaki V(2008)The change of oxidative stress products in diabetes mellitus and diabetic retinopathy Br J Ophthalmol 95 351-358

[15] Le ML(1979)Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction Anal Biochem 41 82-89

[16] Malmkvist G(2017)Hyperlipidemia-mediated increased advanced lipoxidation end products formation, an important factor associated with decreased erythrocyte glucose-6-phosphate dehydrogenase activity in mild nonproliferative diabetic retinopathy Can J Diabetes 22 21-31

[17] Alling C(2010)The prognostic value of NSE and S100B from serum and cerebrospinal fluid in patients with spontaneous subarachnoid hemorrhage J Neurosurg Anesthesiol 37 401-407

[18] Solem JO(2013)Oxidative stress-associated neuroretinal dysfunction and nitrosative stress in diabetic retinopathy Can J Diabetes 27 283-290

[19] Ståhl E(2003)A new view of diabetic retinopathy: a neurodegenerative disease of the eye Prog Neuropsychopharmacol Biol Psychiatry 52 506-511

[20] Guzman DC(2003)A role of the polyol pathway in the early neuroretinal apoptosis and glial changes induced by diabetes in the rat Diabetes 37 1030-1035

[11] Aubert RE(2015)The role of oxidative stress in neurodegenerative diseases Exp Neurobiol. 27 523.e11-523.e19

[12] Herman WH(2012)Plasma levels of oxidative stress biomarkers and hospital mortality in severe head injury: a multivariate analysis J Crit Care 17 1298-1304

[13] Joussen AM(2011)Lipid peroxidation and total antioxidant capacity in vitreous, aqueous humor, and blood samples from patients with diabetic retinopathy Mol Vis 92 548-551

[14] Poulaki V(2008)The change of oxidative stress products in diabetes mellitus and diabetic retinopathy Br J Ophthalmol 95 351-358

[15] Le ML(1979)Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction Anal Biochem 41 82-89

[16] Malmkvist G(2017)Hyperlipidemia-mediated increased advanced lipoxidation end products formation, an important factor associated with decreased erythrocyte glucose-6-phosphate dehydrogenase activity in mild nonproliferative diabetic retinopathy Can J Diabetes 22 21-31

[17] Alling C(2010)The prognostic value of NSE and S100B from serum and cerebrospinal fluid in patients with spontaneous subarachnoid hemorrhage J Neurosurg Anesthesiol 37 401-407

[18] Solem JO(2013)Oxidative stress-associated neuroretinal dysfunction and nitrosative stress in diabetic retinopathy Can J Diabetes 27 283-290

[19] Ståhl E(2003)A new view of diabetic retinopathy: a neurodegenerative disease of the eye Prog Neuropsychopharmacol Biol Psychiatry 52 506-511

[20] Guzman DC(2003)A role of the polyol pathway in the early neuroretinal apoptosis and glial changes induced by diabetes in the rat Diabetes 37 1030-1035